Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 7/20 | 0.34 |
| ▸ | CNR1 | P21554 | 4/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3854701 | 0.94 | PIK3CA (0.37) | CNR2CNR1KITPIK3CAPIK3CB | |
| SCHEMBL3847654 | 0.92 | PIK3CA (0.34) | KITPIK3CAPIK3CBMTORCDK19 | |
| SCHEMBL3846559 | 0.92 | CNR2 (0.34) | CNR2KITPIK3CAPIK3CBMTOR | |
| SCHEMBL3845899 | 0.91 | TP53 (0.33) | KITPIK3CAPIK3CBMTORCDK19 | |
| SCHEMBL3845668 | 0.90 | KIT (0.32) | CNR2KITPIK3CAPIK3CBMTOR | |
| SCHEMBL3847076 | 0.89 | LMNA (0.33) | CNR2KITPIK3CAPIK3CBMTOR | |
| SCHEMBL3852721 | 0.89 | HRH3 (0.32) | KIT | |
| SCHEMBL3845570 | 0.88 | HRH3 (0.36) | KITPIK3CAPIK3CBMTORCDK19 | |
| SCHEMBL3846800 | 0.87 | CNR2 (0.39) | CNR2CNR1SLC2A1KITKCNH2 | |
| SCHEMBL3848153 | 0.85 | ALDH1A1 (0.33) | KITPIK3CAPIK3CBMTORCDK19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |